Chronic heart failure - Impact of the condition on patients and the healthcare system in the Czech Republic: A retrospective cost-of-illness analysis

被引:4
|
作者
Pavlusova, Marie [1 ,2 ]
Klimes, Jiri [3 ,4 ]
Spinar, Jindrich [1 ,2 ]
Zeman, Kamil [5 ]
Jarkovsky, Jiri [6 ]
Benesova, Klara [6 ]
Miklik, Roman [1 ,2 ]
Pohludkova, Ludmila [5 ]
Felsoci, Marian [1 ,2 ]
Vesela, Vera [3 ]
Blahovcova, Michaela [3 ]
Dostal, Filip [3 ]
Vonka, Richard [3 ]
Parenica, Jiri [1 ,2 ]
机构
[1] Univ Hosp Brno, Dept Cardiol, Brno, Czech Republic
[2] Masaryk Univ, Med Fac, Brno, Czech Republic
[3] Novartis Sro, Prague, Czech Republic
[4] Charles Univ Prague, Fac Pharm Hradec Kralove, Prague, Czech Republic
[5] Hosp Frydek Mistek, Dept Internal Med, Frydek Mystek, Czech Republic
[6] Masaryk Univ, Inst Biostat & Anal, Fac Med, Brno, Czech Republic
关键词
Chronic heart failure; Hospitalization costs; Cost-of-illness;
D O I
10.1016/j.crvasa.2018.03.002
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: The number of patients with heart failure is steadily increasing, as are the costs of their treatment. Nearly 70% of the costs associated with the treatment of heart failure are direct medical costs, and 70-80% of these are spent on hospitalizations. The aim of our study is to describe the all-cause hospitalization costs of patients with chronic heart failure (chronic HF) from the perspective of the healthcare system in the Czech Republic. Methods: In total, 1274 consecutively collected patients discharged in a stable condition from hospitalization for acute heart failure (= index hospitalization) from 2006 to 2012 were followed-up for 2 years. Their all-cause mortality and all-cause hospitalizations were retrospectively evaluated. The in-patient costs were calculated based on the relative weights of DRG codes for particular hospitalization events and on the basic DRG tariff for 2013 (CZK 28,898). Results: At the end of the 2-year follow-up, a total of 1511 hospitalizations were recorded. A total of 31.8% of patients survived without any hospitalization, 32.1% of patients survived with at least one hospitalization, and 36.1% of patients died. Re-hospitalizations for acute heart failure accounted for 31.2% of all cases. The average cost for one chronic HF patient hospitalized for any reason was CZK 85,414; the cost for acute heart failure re-hospitalization was CZK 31,320 during the 2-year follow-up period. The cost of all-cause hospitalizations within the first year after the index hospitalization was higher compared to the cost during the second year (CZK 58,528/year vs. CZK 23,082/year). As the estimated number of chronic HF patients is 230,000 (data from the Institute of Health Information and Statistics of the Czech Republic), we can calculate the total cost of all-cause hospitalizations of chronic HF patients to be approximately CZK 7.98 billion per year in the Czech Republic. Conclusion: The data from clinical practice confirm that patients with chronic HF discharged from acute heart failure hospitalization are at high risk of death and/or subsequent hospitalization. The average annual costs for all-cause hospitalizations of CHS patients within the first and second years are CZK 58,528 and CZK 23,082 per patient, respectively. The costs attributed to all-cause hospitalization care of chronic HF patients can be estimated as approximately 7.7% of all annual inpatient expenses of health insurance companies and 2.7% of total healthcare expenditures in the Czech Republic. (C) 2018 The Czech Society of Cardiology. Published by Elsevier Sp. z o.o. All rights reserved.
引用
收藏
页码:E224 / E233
页数:10
相关论文
共 50 条
  • [21] Allogeneic stem cell transplantation in patients with chronic myeloid leukaemia in Czech Republic:: results of a retrospective analysis from the Czech National Registry and Pilsen
    Faber, E
    Vitek, A
    Koza, V
    Mayer, J
    Sedlacek, P
    Zak, P
    Zapletalová, J
    Benesová, K
    Krejcova, H
    Steinerová, K
    Maresová, I
    Cetkovsky, P
    [J]. BONE MARROW TRANSPLANTATION, 2006, 37 : S226 - S226
  • [22] COST-UTILITY ANALYSIS OF HOME TELEMONITORING IN ELDERLY PATIENTS WITH CHRONIC HEART FAILURE
    Stafylas, P.
    Dafoulas, G.
    Aletras, V. H.
    Lashos, V
    Raptis, O.
    [J]. VALUE IN HEALTH, 2008, 11 (06) : A397 - A397
  • [23] COST-EFFECTIVENESS ANALYSIS OF IVABRADINE IN THE TREATMENT OF PATIENTS WITH CHRONIC HEART FAILURE IN IRAN
    Taheri, S.
    Aivazi, A.
    Rasekh, H. R.
    [J]. VALUE IN HEALTH, 2017, 20 (09) : A617 - A617
  • [24] Application of low cost biomarkers score in prognosis analysis of patients with chronic heart failure
    Pena, Felipe Montes
    Pereira, Sabrina Bernardez
    Giro, Camila
    Seixas, Karina
    Barcelos, Amanda Ferreira
    Mesquita, Evandro Tinoco
    [J]. INSUFICIENCIA CARDIACA, 2011, 6 (03) : 117 - 123
  • [25] Longterm cost-effectiveness analysis of a telemedicine programme for patients with chronic heart failure
    Janssen, H.
    [J]. EUROPEAN HEART JOURNAL, 2010, 31 : 226 - 226
  • [26] Impact of loop diuretic dosage in a population of patients with acute heart failure: a retrospective analysis
    Meani, P.
    Pagnoni, M.
    Mondellini, G. M.
    Fiorenza, S.
    Brunner-La Rocca, H. P.
    [J]. FRONTIERS IN CARDIOVASCULAR MEDICINE, 2023, 10
  • [27] IMPACT OF DYSLIPIDEMIA ON CLINICAL OUTCOMES AMONG PATIENTS WITH HEART FAILURE: A NATIONWIDE RETROSPECTIVE ANALYSIS
    Nebuwa, Chikodili Nora
    Iyeku, Akinwale C.
    Ndakotsu, Andrew Kamsoko
    Ugoala, Onyinye Sylvia
    Mandal, Dipesh
    Uwumiro, Fidelis
    Bewley, Benoit
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2024, 83 (13) : 633 - 633
  • [28] Cost-of-illness analysis of long-term healthcare resource utilization and disease burden in patients with pulmonary embolism: insights from the PREFER in VTE registry
    Farmakis, I.
    Barco, S.
    Mavromanoli, A. C.
    Mahan, C. E.
    Giannakoulas, G.
    Cohen, A. T.
    Konstantinides, S.
    Valerio, L.
    [J]. EUROPEAN HEART JOURNAL, 2022, 43 : 1894 - 1894
  • [29] Treatment patterns in patients with chronic heart failure in Germany: a retrospective study of the health risk institute healthcare claims database
    Hupfer, S.
    Calado, F.
    Souto, D.
    Handrock, R.
    Jacob, J.
    Walker, J.
    Klebs, S.
    [J]. EUROPEAN JOURNAL OF HEART FAILURE, 2016, 18 : 190 - 190
  • [30] Healthcare burden of probable and proven invasive mucormycosis: a multi-centre cost-of-illness analysis of patients treated in tertiary care hospitals between 2003 and 2016
    Heimann, S. M.
    Vehreschild, M. J. G. T.
    Cornely, O. A.
    Heinz, W. J.
    Gruener, B.
    Silling, G.
    Kessel, J.
    Seidel, D.
    Vehreschild, J. J.
    [J]. JOURNAL OF HOSPITAL INFECTION, 2019, 101 (03) : 339 - 346